Cargando…
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?
Since the beginning of the Coronavirus disease (COVID)-19 pandemic in December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for more than 600 million infections and 6.5 million deaths worldwide. Given the persistence of SARS-CoV-2 and its ability to dev...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685122/ https://www.ncbi.nlm.nih.gov/pubmed/36422774 http://dx.doi.org/10.1007/s12015-022-10477-y |